CHNG:NSD-Change Healthcare Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 22.32

Change

+0.13 (+0.59)%

Market Cap

USD 6.88B

Volume

1.32M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. The Network Solutions segment provides solutions for financial, administrative, and clinical and pharmacy transactions; connected consumer health; intelligent healthcare network; electronic business-to-business and consumer-to-business payments; data; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment offers solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. The company serves commercial insurers, private insurers, BlueCross Blue Shield plans, Medicare/Medicaid plans, provider-sponsored payers, third party administrators, emerging technology and data-driven health plans, and other specialty health benefits insurers, as well as hospitals and health systems, physician practices, dentists, pharmacies, skilled nursing facilities, home health agencies, telehealth providers, senior care facilities, laboratories, and other healthcare providers. Change Healthcare Inc. was incorporated in 2016 and is headquartered in Nashville, Tennessee.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-22 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CERN Cerner Corporation

+0.37 (+0.48%)

USD23.41B 29.74 13.34
TXG 10x Genomics, Inc

+1.83 (+0.99%)

USD18.94B N/A N/A
GDRX GoodRx Holdings, Inc

+0.12 (+0.38%)

USD12.32B 927.27 238.21
OMCL Omnicell, Inc

+0.82 (+0.54%)

USD6.53B 192.47 54.71
HQY HealthEquity, Inc

-1.25 (-1.65%)

USD6.31B 1,327.54 45.19
RCM R1 RCM Inc

+0.17 (+0.83%)

USD5.70B 72.63 29.55
INOV Inovalon Holdings, Inc

-0.13 (-0.40%)

USD5.12B 151.29 28.92
PGNY Progyny, Inc

-0.71 (-1.25%)

USD4.96B 96.42 250.90
PINC Premier, Inc

+0.05 (+0.14%)

USD4.36B 17.42 12.50
CVET Covetrus, Inc

-0.60 (-2.38%)

USD3.47B 40.87 17.97

ETFs Containing CHNG

Symbol Name Weight Mer Price(Change) Market Cap
SRLN SPDR Blackstone Senior Lo.. 0.00 % 0.70 %

N/A

USD6.27B
EVFTC Eaton Vance Floating-Rate.. 0.00 % 0.76 %

N/A

USD5.15M

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.68% 68% D+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.68% 68% D+ 69% D+
Trailing 12 Months  
Capital Gain 94.93% 85% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 94.93% 85% B 82% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 25.92% 54% F 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.92% 54% F 72% C-
Risk Return Profile  
Volatility (Standard Deviation) 45.25% 50% F 39% F
Risk Adjusted Return 57.28% 62% D- 75% C
Market Capitalization 6.88B 90% A- 89% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.13 81% B- 59% F
Price / Cash Flow Ratio 11.74 47% F 34% F
EV/EBITDA 16.94 74% C 49% F
Management Effectiveness  
Return on Equity -3.43% 54% F 52% F
Return on Invested Capital 1.66% 67% D+ 58% F
Return on Assets 0.33% 60% D- 48% F
Debt to Equity Ratio 145.59% 11% F 13% F
Technical Ratios  
Short Ratio 6.06 50% F 18% F
Short Percent 4.59% 60% D- 40% F
Beta 1.50 22% F 29% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.